- Home
- RRGB vs CLRB Comparison
RRGB vs CLRB Comparison
Compare RRGB & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- CLRB
- Stock Information
- Founded
- RRGB 1969
- CLRB 2002
- Country
- RRGB United States
- CLRB United States
- Employees
- RRGB N/A
- CLRB N/A
- Industry
- RRGB Restaurants
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- CLRB Health Care
- Exchange
- RRGB Nasdaq
- CLRB Nasdaq
- Market Cap
- RRGB 81.3M
- CLRB 76.0M
- IPO Year
- RRGB 2002
- CLRB N/A
- Fundamental
- Price
- RRGB $5.15
- CLRB $2.04
- Analyst Decision
- RRGB Strong Buy
- CLRB Strong Buy
- Analyst Count
- RRGB 3
- CLRB 2
- Target Price
- RRGB $12.50
- CLRB $21.00
- AVG Volume (30 Days)
- RRGB 378.8K
- CLRB 237.5K
- Earning Date
- RRGB 11-06-2024
- CLRB 11-18-2024
- Dividend Yield
- RRGB N/A
- CLRB N/A
- EPS Growth
- RRGB N/A
- CLRB N/A
- EPS
- RRGB N/A
- CLRB N/A
- Revenue
- RRGB $1,272,359,000.00
- CLRB N/A
- Revenue This Year
- RRGB N/A
- CLRB N/A
- Revenue Next Year
- RRGB $1.34
- CLRB N/A
- P/E Ratio
- RRGB N/A
- CLRB N/A
- Revenue Growth
- RRGB N/A
- CLRB N/A
- 52 Week Low
- RRGB $2.97
- CLRB $1.82
- 52 Week High
- RRGB $12.80
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- RRGB 44.63
- CLRB 50.95
- Support Level
- RRGB $4.91
- CLRB $2.06
- Resistance Level
- RRGB $6.39
- CLRB $2.18
- Average True Range (ATR)
- RRGB 0.41
- CLRB 0.08
- MACD
- RRGB -0.15
- CLRB 0.01
- Stochastic Oscillator
- RRGB 22.58
- CLRB 52.17
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.